Прогностична роль васкулоендотеліального фактора росту А в пацієнтів, які перенесли гострий інфаркт міокарда

М.П. Копиця, І.М. Кутя, Ю.В. Родіонова, Я.В. Гільова

Література  

1. Оrder of the Ministry of Health of Ukraine N 455. 02.07.2014 (in Ukr).
2. Berezin AE. Predictive Role of Circulating Vascular Endothelial Growth Factor-1 in Patients with Cardiovascular Diseases. J Dis Markers. 2014;1(3):1-6. doi: 10.4172/2165-8048.S11-006
3. Deuse T, Peter C, Fedak PW, Doyle T, Reichenspurner H, Zimmermann WH, Eschenhagen T, Stein W, Wu JC, Robbins RC and Schrepfer S. Hepatocyte growth factor or vascular endothelial growth factor gene transfer maximizes mesenchymal stem cell-based myocardial salvage after acute myocardial infarction. Circulation. 2009;120(11):S247-54. doi: 10.1161/CIRCULATIONAHA.108.843680
4. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med. 2003;9:669-676. doi: 10.1038/nm0603-669
5. Garcia R, Bouleti C, Sirol M, Logeart D, Monnot C, Ardidie-Robouant C. VEGF-A plasma levels are associated with microvascular obstruction in patients with ST-segment elevation myocardial infarction. Int J Cardiol. 2019;291:19-24. doi: 10.1016/j.ijcard.2019.02.067
6. Hagikura K, Fukuda N, Yokoyama S, Yuxin L, Kusumi Y, Matsumoto T, Ikeda Y, Kunimoto S, Takayama T, Jumabay M, Mitsumata M, Saito S, Hirayama A, Mugishima H. Low invasive angiogenic therapy for myocardial infarction by retrograde transplantation of mononuclear cells expressing the VEGF gene. Int J Cardiol. 2010;142:56-64. doi: 10.1016/j.ijcard.2008.12.108 Epub 2009 Jan 24.
7. Heeschen C, Dimmeler S, Hamm CW, Boersma E, Zeiher AM and Simoons ML;and on Behalf of the CAPTURE (c7E3 Anti-Platelet Therapy in Unstable REfractory angina) Investigators:Prognostic significance of angiogenic growth factor serum levels in patients with acute coronary syndromes. Circulation. 2003;107:524-530. doi: 10.1161/01.CIR.0000048183.37648.1A
8. Hoeben A, Landuyt B, Highley MS, Wildiers H, Van Oosterom AT, De Bruijn EA. Vascular endothelial growth factor and angiogenesis. Pharmacol Rev. 2004;56(4):549-80. doi: 10.1124/pr.56.4.3
9. Hojo Y, Ikeda U, Zhu Y, Okada M, Ueno S, Arakawa H, Fujikawa H, Katsuki T and Shimada K. Expression of vascular endothelial growth factor in patients with acute myocardial infarct. J Am Coll Cardiol. 2000;35:968-973. doi: 10.1016/s0735-1097(99)00632-4
10. Kranz A, Rau C, Kochs M, Waltenberger J. Elevation of vascular endothelial growth factor-A serum levels following acute myocardial infarction:Evidence for its origin and functional significance. J Mol Cell Cardiol. 2000;32:65-72. doi: 10.1006/jmcc.1999.1062
11. Lee KW, Lip GY, Blann AD. Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor tie-2 and vascular endothelial growth factor levels in acute coronary syndromes. Circulation. 2004;110:2355-2360. doi: 10.1161/01.CIR.0000138112.90641.7F
12. Matsudaira K, Maeda K, Okumura N, Yoshikawa D, Morita Y, Mitsuhashi H, Ishii H, Kondo T and Murohara T;Nagoya Acute Myocardial Infarction Study (NAMIS) Group:Impact of low levels of vascular endothelial growth factor after myocardial infarction on 6-month clinical outcome:Results from the Nagoya Acute Myocardial Infarction Study. Circ J. 2012;76:1509-151. doi: 10.1253/circj.CJ-11-1127
13. Niu J, Han X, Qi H. :Jiamin Niu, Xia Han, Huaxin Qi, Jie Yin, Zhiqiang Zhang. Correlation between vascular endothelial growth factor and long-term prognosis in patients with acute myocardial infarction. Experimental and Therapeutic Medicine. 2016;12(1):475-479. doi: 10.3892/etm.2016.3286
14. Ogawa H, Suefuji H, Soejima H, Nishiyama K, Misumi K, Takazoe K, Miyamoto S, Kajiwara I, Sumida H, Sakamoto T, et al. Increased blood vascular endothelial growth factor levels in patients with acute myocardial infarction. Cardiology. 2000;93:93-99. doi: 10.1159/000007008
15. Pannitteri G, Petrucci E, Testa U. Coordinate release of angiogenic growth factors after acute myocardial infarction:evidence of a two-wave production. J Cardiovasc Med. 2006;7(12):872-879. doi: 10.2459/01.JCM.0000253831.61974.b9
16. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P. ESC Scientific Document Group. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure:the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016;18:891-975. doi: 10.1093/eurheartj/ehw128
17. Ramos K, Napoleao P, Selas M, Freixo C, Viegas Crespo AM, Carmo MM, Ferreira RC, and Pinheiro T. Prognostic value of VEGF in patients submitted to percutaneous coronary intervention. Hindawi Publishing Corporation. 2014. Article ID:135357, 7 pages. doi: 10.1155/2014/135357
18. Shintani S, Murohara T, Ikeda H, Ueno T, Honma T, Katoh A, Sasaki K, Shimada T, Oike Y. Imaizumi T. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation. 2001;103:2776-2779. doi: 10.1161/hc2301.092122
19. Soeki T, Tamura Y, Shinohara H, Tanaka H, Bando K and Fukuda N. Serial changes in serum VEGF and HGF in patients with acute myocardial infarction. Cardiology. 2000;93:168-174. doi: 10.1159/000007022
20. Soeki T, Tamura Y, Shinohara H, Sakabe K, Onose Y, Fukuda N. Serum hepatocyte growth factor predicts ventricular remodeling following myocardial infarction. Circ J. 2002;66:1003-1007. doi: 10.1253/circj.66.1003
21. Taimeh Z, Loughran J, Birks EJ, Bolli R. Vascular endothelial growth factor in heart failure. Nat Rev Cardiol. 2013;10(9):519-530. doi: 10.1038/nrcardio.2013.94 Epub 2013 Jul 16.
22. Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD;ESC Scientific Document Group. Fourth universal definition of myocardial infarction (2018). Eur Heart J. 2019;40(3):237-269. doi: 10.1093/eurheartj/ehy462
23. Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V, Desormais I;ESC Scientific Document Group. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021-3104. doi: 10.1093/eurheartj/ehy339
24. Ye L, Zhang W, Su LP, Haider HK, Poh KK, Galupo MJ, Songco G, Ge RW, Tan HC and Sim EK:Nanoparticle based delivery of hypoxia-regulated VEGF transgene system combined with myoblast engraftment for myocardial repair. Biomaterials. 2011;32:2424-2431. doi: 10.1016/j.biomaterials.2010.12.008
25. Yin R, Feng J, Chen D and Wu H. Serum levels of vascular endothelial growth factor in patients with anginapectoris and acute myocardial infarct. Chin Med Sci J. 2000;15:205-209. PMID:12906138
26. Zhao T, Zhao W, Chen Y, Ahokas RA, Sun Y. Vascular endothelial growth factor (VEGF)-A:role on cardiac angiogenesis following myocardial infarction. Microvasc Research. 2010;80(2):188-194. doi: 10.1016/j.mvr.2010.03.014

[PDF] [Зміст журналу]